MIT, E8 Sue Navigenics Over Genetic Testing Patent

Law360, New York (May 20, 2009, 12:00 AM EDT) -- The Massachusetts Institute of Technology and E8 Pharmaceuticals LLC have sued Navigenics Inc., claiming the genetics testing company infringes MIT's patent for genetic analysis.

In a complaint filed Tuesday in the U.S. District Court for the District of Massachusetts, MIT and E8, which licenses the patent from MIT, claim that Navigenics infringes the patent by providing commercial genetic counseling and clinical testing services using products manufactured by another genetic analysis company.

MIT claims that it is the assignee of the patent-at-issue in the suit, U.S. Patent...
To view the full article, register now.